FierceBiotech

FDA Approves XARELTO® (rivaroxaban tablets) to Help Prevent Deep Vein Thrombosis in Patients Undergoing Knee or Hip Replacement

XARELTO® is the only new oral anticoagulant with FDA approval in this indication Raritan, NJ (July 1, 2011) /PRNewswire/ - Janssen Pharmaceuticals, Inc. announced today that the U.S. Food and Drug ...
Washington Examiner

FDA OKs expanded uses for Xarelto blood thinner

NEW YORK (AP) — Johnson & Johnson’s Xarelto received an expanded indication as the Food and Drug Administration on Friday approved the blood thinner both to treat and to reduce the risk of recurrence ...
Drug Store News

Aurobindo Pharma receives FDA OK for generic Xarelto

Aurobindo has obtained the Food and Drug Administration’s green light for rivaroxaban tablets, 2.5 mg, which is the generic of Janssen’s Xarelto. Rivaroxaban tablets are used to reduce the risk of ...
Reuters

Bayer submits Xarelto in Japan for marketing approval

FRANKFURT, May 28 (Reuters) - Bayer AG said it has submitted anti-clotting drug Xarelto for marketing authorisation in Japan for the treatment of deep vein thrombosis and pulmonary embolism, the ...
Drug Store News

Alembic obtains FDA’s tentative nod for generic Xarelto

The Food and Drug Administration has given tentative approval to Alembic's rivaroxaban tablets in dosage strengths of 10 mg, 15 mg, and 20 mg. The product is the generic of Janssen’s Xarelto tablets, ...
TCTMD

FDA Approves XARELTO® (rivaroxaban) to Reduce the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation

RARITAN, NJ, Janssen Pharmaceuticals, Inc. announced today the U.S. Food and Drug Administration (FDA) has approved XARELTO® to reduce the risk of stroke and systemic embolism in patients with ...
National Institute for Health and Care Excellence

Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism

Pulmonary embolism (acute treatment, VTE prevention - rivaroxaban: appendix A draft scope for consultation (post referral) October 2012 Pulmonary embolism (acute treatment, VTE prevention - ...
Reuters

Blood thinner drug Xarelto tied to higher rate of major side effects - study

Dec 21 (Reuters) - Older adults taking Bayer AG's (BAYGn.DE), opens new tab blockbuster blood thinner pill Xarelto for a common type of irregular heart rhythm had significantly higher rates of serious ...
AOL

Does Medicare cover Xarelto?

Medicare Part D and Medicare Advantage plans with prescription drug coverage may cover Xarelto if it appears on the plan’s formulary. A generic version of Xarelto (rivaroxaban) recently became ...
Nasdaq

Blood thinner drug Xarelto tied to more major side-effects - study

Older adults taking Bayer AG's blockbuster blood thinner pill Xarelto for a common type of irregular heart rhythm had significantly higher rates of serious bleeding and stroke compared to those taking ...
AOL

Does Medicare cover Xarelto?

Medicare Part D and Medicare Advantage plans with prescription drug coverage may cover Xarelto if it appears on the plan’s formulary. There are currently no generic alternatives available for Xarelto, ...